Study Stopped
Student was unable to start the project due to time constraints
The Relationship Between CFTR Gene Mutations and Exercise Capacity
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This study will explore the effect of mutation severity on exercise capacity. Through a better understanding of the association between mutation severity and exercise capacity, clinicians will be more able to predict a given patient's level of independent functioning based on their genes, which is essential information that patients' families want to know upon diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 1, 2021
CompletedFirst Posted
Study publicly available on registry
December 15, 2021
CompletedStudy Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2022
CompletedSeptember 14, 2022
September 1, 2022
3 months
December 1, 2021
September 9, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in weekly mileage
Participants will report their weekly mileage in a REDCap form
baseline to 10 weeks
Study Arms (1)
Exercise trackers
EXPERIMENTALFitbit physical activity trackers
Interventions
Participants will be asked to wear a Fitbit fitness tracker and report their fitness activity to the study team
Eligibility Criteria
You may qualify if:
- Cystic fibrosis patient who has been tested positive for a CF mutation of class 1-5.
- Part of the VCU cystic fibrosis program.
- Above 18 years old.
You may not qualify if:
- Has not been tested positive for a known CF mutation.
- Not a part of the VCU cystic fibrosis program.
- Cannot be under 18 years old.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Virginia Commonwealth Universitylead
- Cystic Fibrosis Foundationcollaborator
Study Sites (1)
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nauman Chaudary, MD
Virginia Commonwealth University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 1, 2021
First Posted
December 15, 2021
Study Start
August 1, 2022
Primary Completion
November 1, 2022
Study Completion
November 1, 2022
Last Updated
September 14, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share